TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care
Key facts
- Who runs it
- STAVROS G DRAKOS
- Where
- Falls Church and Lexington, United StatesSee the 2 sites
- Trial code
- Status
- Withdrawn
- Started
- 31 Mar 2025
- Ended
- 1 Sept 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- CardioMEMS
- Record updated
- 16 December 2024
- Why it stopped
- Did not receive funding from sponsor
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- Severe clinical HF resistant to intensive medical therapy and requiring LVAD implantation
- Left ventricular ejection fraction <=25% and cardiomegaly at time of LVAD implantation
- Non-ischemic etiology of HF
- Undergone LVAD implantation within prior 4 weeks or planned for LVAD implant
- History of HF < 5 years
- Body Mass Index <=35 kg/m\^2
- Pulmonary artery branch diameter between 7 - 15 mm
- Female subjects of childbearing age with negative urine or serum pregnancy test and agreeing to use reliable mechanical or hormonal form of contraception during study
Who cannot take part
- History of previous cerebrovascular accident resulting in significant fixed motor deficit, limiting ability to perform exercise testing
- Require acute or chronic renal replacement therapy within 3 months prior to enrollment
- Participation in any other clinical investigations involving another Mechanical Circulating Support device or HF-related drug
- Implantation of cardiac re-synchronization therapy < 3 months before enrollment
- Implanted mechanical aortic and/or mitral valve(s) and/or right heart valve(s)
- Irreversible multi-organ failure
- Diagnosis of psychiatric disease, irreversible cognitive dysfunction or poor psycho-social issues likely to impair compliance with study protocol
- Any condition that could limit survival to less than 2 years
- History of cardiac or other organ transplant
- Contraindicated to anti-coagulation, antiplatelet therapy, or diagnosis of coagulation disorders
- Active infection
- History of recurrent (>1) pulmonary embolism or deep vein thrombosis
- Unable to tolerate right heart catheterization
- Congenital heart disease
- Hypersensitivity or allergy to aspirin and/or clopidogrel
- Evidence of active acute myocarditis confirmed by histology
- Aortic valve closure
- Hypertrophic obstructive cardiomyopathy or sarcoidosis
- Left ventricular end-diastolic diameter below normal (restrictive cardiomyopathy)
Where in United States
- Inova Heart and Vascular InstituteFalls Church, United States
- University of KentuckyLexington, United States
About the trial
What the trial wants to find out
This study is a prospective, randomized-controlled, non-blinded, multi-center, pilot trial to compare standard-of-care left ventricular assist device (LVAD) unloading plus heart failure (HF) medications reverse-remodeling management versus hemodynamics-guided LVAD unloading with use of the wireless monitoring system CardioMEMS plus HF medications reverse-remodeling management.
The 2 groups in the trial
- ControlNo study treatment, for comparison
After LVAD implantation, patients undergo cardiac rehab and pump speed will be optimized to maximize left ventricular unloading using echocardiographic imaging and other standard-of-care practices. During the Unloading phase, patients are serially evaluated with echocardiograms to assess for cardiac recovery, and LVAD explantation performed when predefined criteria are met. After explantation, patients undergo cardiac rehab and regular follow up.
- InterventionTreatment being tested
After LVAD and wireless monitoring system (CardioMEMS) implantation, patients undergo cardiac rehab and pump speed will be optimized to maximize left ventricular unloading using CardioMEMS. During the Unloading phase, invasive hemodynamic guidance (via CardioMEMS) will be utilized to optimize pressure and volume unloading along with serial echocardiographic evaluations to assess for cardiac recovery, and LVAD explantation will be considered. After explantation, patients will undergo cardiac rehab and regular follow up with adjustments of HF medications based on the CardioMEMS-guided hemodynamic assessment.
Treatment: CardioMEMS
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective, Randomized-controlled, Non-blinded, Multi-center, Pilot Trial to Compare Standard-of-care LVAD Unloading Plus Heart Failure Medications Reverse-modeling Management Versus Hemodynamics-guided LVAD Unloading with the Use of the Wireless Monitoring System CardioMEMS Plus Heart Failure Medications Reverse-remodeling Management
- Record updated
- 16 December 2024